Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modern Clinical Research on LSD
Matthias E. Liechti
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2114-2127
Open Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

Psychedelics and Psychedelic-Assisted Psychotherapy
Collin Reiff, Elon E. Richman, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 5, pp. 391-410
Closed Access | Times Cited: 451
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Anne Katrin Schlag, Jacob S. Aday, Iram Salam, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 258-272
Open Access | Times Cited: 220
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 210
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid, Matthias E. Liechti
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 535-545
Open Access | Times Cited: 196
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze, Patrick Vizeli, Felix Müller, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 3, pp. 462-471
Open Access | Times Cited: 187
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Rafael G. dos Santos, José Carlos Bouso, Miguel Ángel Alcázar‐Córcoles, et al.
Expert Review of Clinical Pharmacology (2018) Vol. 11, Iss. 9, pp. 889-902
Closed Access | Times Cited: 186
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 184
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Patrick Vizeli, Laura Ley, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 537-544
Open Access | Times Cited: 178
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers, Livia Ng, David Erritzøe, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1039-1057
Open Access | Times Cited: 169
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos, Natasha L. Mason, Kim P. C. Kuypers
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 169
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Laura Ley, Felix Müller, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1180-1187
Open Access | Times Cited: 147
LSD alters dynamic integration and segregation in the human brain
Andrea I. Luppi, Robin Carhart‐Harris, Leor Roseman, et al.
NeuroImage (2020) Vol. 227, pp. 117653-117653
Open Access | Times Cited: 145
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Laura Kaertner, Michael B. Steinborn, Hannes Kettner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 108
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Étienne Billard, Alexandre Torbey, Antonio Inserra, et al.
Cellular Signalling (2025) Vol. 127, pp. 111588-111588
Closed Access | Times Cited: 3
Altered network hub connectivity after acute LSD administration
Felix Müller, Patrick C. Dolder, André Schmidt, et al.
NeuroImage Clinical (2018) Vol. 18, pp. 694-701
Open Access | Times Cited: 160
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial
Steliana Yanakieva, Naya Polychroni, Neiloufar Family, et al.
Psychopharmacology (2018) Vol. 236, Iss. 4, pp. 1159-1170
Open Access | Times Cited: 142
Serotonin toxicity of serotonergic psychedelics
Benjamin Malcolm, Kelan Thomas
Psychopharmacology (2021) Vol. 239, Iss. 6, pp. 1881-1891
Closed Access | Times Cited: 101
Motives and Side-Effects of Microdosing With Psychedelics Among Users
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
The International Journal of Neuropsychopharmacology (2019) Vol. 22, Iss. 7, pp. 426-434
Open Access | Times Cited: 98
Psychedelic microdosing benefits and challenges: an empirical codebook
Thomas Anderson, Rotem Petranker, Adam Christopher, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 97
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea, Nicole Amada, Henrik Jungaberle, et al.
International Journal of Drug Policy (2019) Vol. 75, pp. 102600-102600
Closed Access | Times Cited: 85
Trends in LSD use among US adults: 2015–2018
R. Andrew Yockey, Rebecca A. Vidourek, Keith A. King
Drug and Alcohol Dependence (2020) Vol. 212, pp. 108071-108071
Closed Access | Times Cited: 85
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses
Tingying Chi, Jessica A. Gold
Journal of the Neurological Sciences (2020) Vol. 411, pp. 116715-116715
Open Access | Times Cited: 76
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Kyle T. Greenway, Nicolas Garel, Lisa Jerome, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 6, pp. 655-670
Closed Access | Times Cited: 72
Substance-Induced Psychoses: An Updated Literature Review
A. Fiorentini, Filippo Cantù, Camilla Crisanti, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top